CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rudy Saucillo who wrote (355)	3/17/1998 8:57:00 AM
From: Dr. John M. de Castro	Read Replies (1) of 675

Thanks Rudy for the interesting insight. As you indicated, at $2/share CNSI's stock is selling at cash value. So, $2 buys you $2 in cash and a technology of unknown, but not zero, value. But, in April you will receive $1 cash and the stock price will likely decline to $1/share. The $1 is a taxable dividend. So, you get less than $1 for your $1. Looks like a bad deal from here. However, after the April dividend, you can pay $1 for $1 in cash and the same technology that you had to pay $2 to access now. The purchase price is still entirely offset by the cash. Your gain is entirely dictated by the value of the technology. But, you can get it at half the cost. Correct me if I'm wrong, but, I think that I'll wait. I'd appreciate hearing comments regarding what the worth of the technology is. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next